"This is not charity - this is global security".
Access and equal distribution of vaccines are essential in managing the ongoing COVID-19 pandemic. The current challenges of vaccine inequality demand a re-examination of the vaccine distribution mechanisms. What are the consequences of wealthier nations grabbing most of the global vaccine supply? How does it affect pandemic control on a local and global scale? What are the current models for vaccine distribution in Norway and beyond and are there more just and fair possible alternatives?
This episode is a recording of the Vaccine Inequality Webinar held at Bergen Global 20.05 2021 by GRIP and the UiB Pandemic centre. The webinar was hosted by Bjørn Enge Bertelsen and Esperanza Diaz, and the panellists were:
Dr John-Arne Røttingen: Røttingen is Norway’s global health ambassador and oversees Norway`s global health efforts and participation in international activities to combat Covid-19.
Dr Mosoka P Fallah: Fallah is the Founder and Executive Director of Refuge Place International, an NGO in Liberia addressing access to affordable quality health care for poor urban and rural dwellers.
Professor Gagandeep Kang: Kang is a Professor of Microbiology at the Wellcome Trust Research Laboratory at the Christian Medical College (CMC) in Vellore, and she is one of India’s leading experts on vaccines.
Professor Henriette Sinding Aasen: A professor of law from the University of Bergen, she is a well-established researcher in the field of health and human rights, including access to healthcare services for vulnerable groups and the relationship between welfare state regulations and social citizenship.
Erlend Grønningen: Grønningen is a board member of Médecins Sans Frontières/Doctors without Borders and has been the acting spokesperson for MSF in Norway throughout the COVID-19 pandemic.
You can read our miniseries interview "Inequality in the (Post-) Pandemic City: The Paradox of Geography and Vaccine" with dr. Fallah here.
Cover photo: MF Photo/ERNESTO BENAVIDES
***************************************************
GRIP newsletter
Twitter - Facebook - Instagram
***************************************************
